APA (7th ed.) Citation

Hohmann, N., Kocheise, F., Carls, A., Burhenne, J., Weiß, J., Haefeli, W. E., & Mikus, G. (2016). Dose-dependent bioavailability and CYP3A inhibition contribute to non-linear pharmacokinetics of voriconazole. Clinical pharmacokinetics, 55(12), . https://doi.org/10.1007/s40262-016-0416-1

Chicago Style (17th ed.) Citation

Hohmann, Nicolas, Franziska Kocheise, Alexandra Carls, Jürgen Burhenne, Johanna Weiß, Walter E. Haefeli, and Gerd Mikus. "Dose-dependent Bioavailability and CYP3A Inhibition Contribute to Non-linear Pharmacokinetics of Voriconazole." Clinical Pharmacokinetics 55, no. 12 (2016). https://doi.org/10.1007/s40262-016-0416-1.

MLA (9th ed.) Citation

Hohmann, Nicolas, et al. "Dose-dependent Bioavailability and CYP3A Inhibition Contribute to Non-linear Pharmacokinetics of Voriconazole." Clinical Pharmacokinetics, vol. 55, no. 12, 2016, https://doi.org/10.1007/s40262-016-0416-1.